Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| United States Department of Veterans Affairs | 12 | 2022 | 307 | 2.860 |
Why?
|
| Veterans | 15 | 2022 | 904 | 1.980 |
Why?
|
| Hypertension | 11 | 2018 | 1531 | 1.930 |
Why?
|
| Hospitalization | 8 | 2018 | 977 | 1.690 |
Why?
|
| Antihypertensive Agents | 6 | 2018 | 497 | 1.600 |
Why?
|
| Heart Failure | 7 | 2018 | 1179 | 1.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2021 | 1085 | 1.510 |
Why?
|
| Blood Pressure | 5 | 2018 | 1447 | 1.070 |
Why?
|
| Delivery of Health Care | 3 | 2018 | 445 | 1.020 |
Why?
|
| Rural Population | 3 | 2018 | 397 | 0.970 |
Why?
|
| Patient Readmission | 5 | 2016 | 267 | 0.970 |
Why?
|
| Emergency Service, Hospital | 4 | 2018 | 711 | 0.950 |
Why?
|
| United States | 26 | 2022 | 7335 | 0.940 |
Why?
|
| Medication Adherence | 6 | 2020 | 335 | 0.900 |
Why?
|
| Hypoglycemic Agents | 7 | 2019 | 361 | 0.860 |
Why?
|
| Quality Improvement | 3 | 2015 | 413 | 0.850 |
Why?
|
| Diabetes Mellitus | 5 | 2020 | 693 | 0.840 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2020 | 467 | 0.820 |
Why?
|
| Mortality | 2 | 2018 | 162 | 0.770 |
Why?
|
| Health Care Costs | 4 | 2018 | 346 | 0.760 |
Why?
|
| Aged | 25 | 2021 | 14842 | 0.740 |
Why?
|
| Medicare | 7 | 2021 | 316 | 0.730 |
Why?
|
| Mental Disorders | 2 | 2015 | 659 | 0.690 |
Why?
|
| Rural Health Services | 1 | 2020 | 101 | 0.680 |
Why?
|
| Episode of Care | 1 | 2018 | 12 | 0.660 |
Why?
|
| Retrospective Studies | 20 | 2022 | 7264 | 0.650 |
Why?
|
| Health Services | 1 | 2018 | 87 | 0.610 |
Why?
|
| Urban Population | 2 | 2018 | 254 | 0.600 |
Why?
|
| Male | 32 | 2021 | 37281 | 0.590 |
Why?
|
| Humans | 43 | 2022 | 68525 | 0.580 |
Why?
|
| Internship and Residency | 2 | 2014 | 596 | 0.570 |
Why?
|
| Glycemic Index | 1 | 2016 | 28 | 0.570 |
Why?
|
| Community Health Services | 1 | 2017 | 141 | 0.560 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 581 | 0.560 |
Why?
|
| Depression | 2 | 2016 | 942 | 0.560 |
Why?
|
| Blood Glucose | 3 | 2016 | 631 | 0.540 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 212 | 0.540 |
Why?
|
| Female | 30 | 2021 | 38015 | 0.530 |
Why?
|
| Cohort Studies | 11 | 2021 | 2356 | 0.510 |
Why?
|
| Transportation of Patients | 1 | 2015 | 46 | 0.500 |
Why?
|
| Health Personnel | 1 | 2017 | 286 | 0.500 |
Why?
|
| Feedback, Psychological | 1 | 2014 | 17 | 0.490 |
Why?
|
| Decision Making | 1 | 2018 | 410 | 0.490 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 84 | 0.490 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 235 | 0.470 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 170 | 0.470 |
Why?
|
| Residence Characteristics | 3 | 2020 | 252 | 0.460 |
Why?
|
| Middle Aged | 19 | 2022 | 21119 | 0.460 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 172 | 0.450 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1054 | 0.440 |
Why?
|
| Ambulatory Care | 1 | 2015 | 339 | 0.430 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 281 | 0.420 |
Why?
|
| Patient Care Team | 1 | 2014 | 311 | 0.420 |
Why?
|
| Mental Health | 1 | 2014 | 278 | 0.410 |
Why?
|
| Patient Discharge | 1 | 2014 | 294 | 0.410 |
Why?
|
| Telemedicine | 1 | 2020 | 699 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 503 | 0.400 |
Why?
|
| Reimbursement, Incentive | 1 | 2011 | 25 | 0.390 |
Why?
|
| Chronic Pain | 2 | 2022 | 110 | 0.380 |
Why?
|
| Health Status Disparities | 3 | 2020 | 326 | 0.370 |
Why?
|
| Quality Indicators, Health Care | 1 | 2011 | 136 | 0.360 |
Why?
|
| Enoxaparin | 1 | 2010 | 51 | 0.360 |
Why?
|
| Drug Utilization | 1 | 2010 | 119 | 0.350 |
Why?
|
| Iliac Aneurysm | 1 | 2008 | 7 | 0.340 |
Why?
|
| Renal Artery Obstruction | 1 | 2008 | 29 | 0.340 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2008 | 13 | 0.340 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 124 | 0.330 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 4843 | 0.330 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 298 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2010 | 766 | 0.310 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 253 | 0.300 |
Why?
|
| Thrombosis | 1 | 2008 | 218 | 0.300 |
Why?
|
| Comorbidity | 6 | 2019 | 1425 | 0.300 |
Why?
|
| Anticoagulants | 1 | 2010 | 356 | 0.300 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 442 | 0.300 |
Why?
|
| Vitamin D | 1 | 2011 | 516 | 0.300 |
Why?
|
| Qualitative Research | 2 | 2018 | 368 | 0.280 |
Why?
|
| Drug Prescriptions | 3 | 2019 | 135 | 0.270 |
Why?
|
| Odds Ratio | 2 | 2018 | 880 | 0.260 |
Why?
|
| Nutrition Surveys | 3 | 2011 | 204 | 0.260 |
Why?
|
| Acute Disease | 2 | 2018 | 658 | 0.220 |
Why?
|
| Hospitals | 2 | 2016 | 265 | 0.220 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 791 | 0.220 |
Why?
|
| Adult | 11 | 2019 | 21375 | 0.200 |
Why?
|
| Disease Management | 2 | 2015 | 248 | 0.200 |
Why?
|
| Bias | 2 | 2020 | 148 | 0.200 |
Why?
|
| Buprenorphine | 1 | 2021 | 67 | 0.190 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 1046 | 0.190 |
Why?
|
| Veterans Health | 1 | 2020 | 61 | 0.180 |
Why?
|
| Prevalence | 4 | 2018 | 1609 | 0.180 |
Why?
|
| South Carolina | 3 | 2016 | 2750 | 0.180 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 161 | 0.180 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 378 | 0.180 |
Why?
|
| Dyslipidemias | 1 | 2020 | 98 | 0.180 |
Why?
|
| Hospitals, Veterans | 2 | 2020 | 147 | 0.180 |
Why?
|
| Biometry | 1 | 2020 | 72 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 96 | 0.170 |
Why?
|
| Multimorbidity | 1 | 2018 | 7 | 0.160 |
Why?
|
| Geographic Mapping | 1 | 2018 | 19 | 0.160 |
Why?
|
| Incidence | 2 | 2015 | 1582 | 0.160 |
Why?
|
| Insurance Claim Review | 1 | 2016 | 39 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3256 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 2264 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 346 | 0.140 |
Why?
|
| Perception | 1 | 2017 | 189 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2018 | 168 | 0.140 |
Why?
|
| Hypertension, Renal | 1 | 2015 | 29 | 0.140 |
Why?
|
| Risk Factors | 3 | 2016 | 5719 | 0.140 |
Why?
|
| Time Factors | 3 | 2020 | 4655 | 0.140 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 53 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2018 | 383 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2018 | 322 | 0.130 |
Why?
|
| Disabled Persons | 1 | 2015 | 94 | 0.130 |
Why?
|
| Nursing Homes | 1 | 2015 | 54 | 0.130 |
Why?
|
| Disease Progression | 1 | 2018 | 1037 | 0.130 |
Why?
|
| Transitional Care | 1 | 2013 | 5 | 0.120 |
Why?
|
| Program Development | 1 | 2015 | 240 | 0.120 |
Why?
|
| Hospital Mortality | 2 | 2015 | 384 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 521 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 938 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 503 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 438 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 146 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2018 | 702 | 0.100 |
Why?
|
| Logistic Models | 2 | 2020 | 1419 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2011 | 223 | 0.100 |
Why?
|
| Professional Practice | 1 | 2010 | 47 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 87 | 0.090 |
Why?
|
| Pneumonia | 1 | 2011 | 110 | 0.090 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 65 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2010 | 169 | 0.090 |
Why?
|
| Diuretics | 1 | 2010 | 96 | 0.090 |
Why?
|
| Thromboembolism | 1 | 2010 | 91 | 0.090 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 137 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 189 | 0.090 |
Why?
|
| Infarction | 1 | 2008 | 17 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 201 | 0.090 |
Why?
|
| Health Policy | 1 | 2011 | 221 | 0.080 |
Why?
|
| Inpatients | 1 | 2010 | 208 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2010 | 714 | 0.080 |
Why?
|
| Urban Health | 2 | 2020 | 49 | 0.080 |
Why?
|
| Rural Health | 2 | 2020 | 66 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 181 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 955 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 498 | 0.070 |
Why?
|
| Length of Stay | 1 | 2010 | 780 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2010 | 1737 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 807 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 1139 | 0.070 |
Why?
|
| Sex Factors | 2 | 2020 | 1265 | 0.060 |
Why?
|
| Kidney | 1 | 2008 | 945 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7028 | 0.060 |
Why?
|
| Geography | 1 | 2020 | 80 | 0.050 |
Why?
|
| Ethnology | 1 | 2018 | 5 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2323 | 0.040 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 32 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 170 | 0.040 |
Why?
|
| Models, Economic | 1 | 2018 | 69 | 0.040 |
Why?
|
| Obesity | 2 | 2018 | 1074 | 0.040 |
Why?
|
| Insulin | 2 | 2011 | 617 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2018 | 239 | 0.040 |
Why?
|
| Health Services Research | 1 | 2018 | 209 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2018 | 249 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2016 | 99 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 2093 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 621 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1593 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 705 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1465 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 8903 | 0.030 |
Why?
|
| Medicaid | 1 | 2016 | 301 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2004 | 0.030 |
Why?
|
| Cost Savings | 1 | 2012 | 110 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1851 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 563 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 411 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1860 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 648 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 446 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2011 | 307 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 866 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5708 | 0.020 |
Why?
|